Preparation and characterization of the poly(2-hydroxyethyl methacrylate)–salicylic acid conjugate
- 301 Downloads
A new polymeric system containing hydrolysable ester bond linked to salicylic acid to be used for controlled drug release was synthesized. Poly(2-hydroxyethyl methacrylate) (PHEMA) functionalized with chloroacetate groups was obtained by the reaction between PHEMA and chloroacetyl chloride using the N,N-dimethylacetamide/5% lithium chloride system as a solvent and pyridine as a catalyst. The degree of substitution was calculated from the chlorine content and ranged from 32.2 to 98.1 mol.% depending on the ratio of chloroacetyl chloride to PHEMA. The coupling of salicylic acid to PHEMA functionalized with chloroacetate groups was carried out by the reaction between PHEMA and the sodium salt of salicylic acid. The structures of chloroacetylated PHEMA and PHEMA–salicylic acid conjugates were determined by means of FTIR, 1H-NMR and 13C-NMR spectra. The hydrolysis in the heterogeneous system of PHEMA–salicylic acid conjugates were performed in buffer solutions (pH 7.6 and 8.5) at 37 °C and showed that the release of the drug (sodium salicylate) from tablets was dependent on the hydrophilic character of conjugate as well as on the pH value of the medium.
KeywordsPolymer–drug conjugate Poly(2-hydroxyethyl methacrylate) Chloroacetylation Sodium salicylate Controlled release
- 15.Won ChY, Chu ChCh, Yu T (1997) Synthesis of starch-based drug carrier for the control/release of estrone hormone. J Carbohydr Res 32:239Google Scholar
- 22.Chang CH, Sheu YM, Hu WP, Wang LF, Chen JS (1998) Synthesis and properties of copolymers 2-hydroxyethyl methacrylate-linked nonsteroidal antinflammatory agents with methacrylic acid. J Polym Sci Symp 36:1481Google Scholar
- 27.Harris FW (1984) Controlled release from polymers containing pendent bioactive substituents. In: Langer RS, Wise DL (eds) Medical application of controlled release. CRC, Boca Raton, FL, 103 ppGoogle Scholar